Inspire Medical (INSP) Insider Plans $1.03M Stock Sale of 11,000 Shares

Rhea-AI Filing Summary

Inspire Medical Systems (INSP) filed a Form 144 notifying a proposed sale of 11,000 common shares through RBC Capital Markets on 08/29/2025 on the NYSE, with an aggregate market value of $1,027,349.00. The filing reports 29,574,316 shares outstanding, so the proposed block represents roughly 0.04% of outstanding shares. All 11,000 shares were acquired by option exercise between 06/30/2019 and 10/09/2020, totaling the same 11,000 shares listed for sale. No securities were sold by the filer in the past three months, and the filer certifies no undisclosed material adverse information.

Insights

Securities Analyst

Routine insider sale notice; small volume relative to float, limited market impact.

The Form 144 documents a proposed sale of 11,000 common shares valued at about $1.03 million, executed through a broker on a specified date. The shares were acquired via option exercises from 2019–2020, indicating these are previously granted equity awards being monetized rather than new dilution. At ~0.04% of outstanding shares, the position is immaterial to the company capitalization and unlikely to affect market liquidity or share price materially.

Corporate Governance Expert

Disclosure aligns with Rule 144 requirements; signer affirms absence of undisclosed material information.

The filing contains the required seller representations and acquisition history supporting compliance with Rule 144 resale conditions. The absence of sales in the prior three months and the statement that the filer is unaware of undisclosed material adverse information reduce governance concerns. This is a standard liquidity event for an insider who exercised options previously.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
COMMON	RBC CAPITAL MARKETS LLC 250 NICOLLET MALL, SUITE 1700 MINNEAPOLIS MN 55401	11000	1027349.00	29574316	08/29/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
COMMON	06/30/2019	OPTION EXERCISE	ISSUER			356	06/30/2019	N/A
COMMON	12/31/2019	OPTION EXERCISE	ISSUER			165	12/31/2019	N/A
COMMON	06/30/2020	OPTION EXERCISE	ISSUER			197	06/30/2020	N/A
COMMON	07/22/2020	OPTION EXERCISE	ISSUER			7786	07/22/2020	N/A
COMMON	07/22/2020	OPTION EXERCISE	ISSUER			500	07/22/2020	N/A
COMMON	10/09/2020	OPTION EXERCISE	ISSUER			1996	10/09/2020	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)